B06 - SABRE hyperpolarization to quantify low concentration metabolites for early disease diagnosis

since 2023

B06 develops a new platform for metabolomic classification in body fluids and its application. At its core, this platform is based on compact high-field NMR, while the sensitivity enhanced by parahydrogen hyperpolarization. The platform operates on a three-step process: preparation of a body fluid equivalent; parahydrogen-based hyperpolarization; sensitive NMR detection. While the platform itself is designed for generalized metabolite detection at low concentrations, special emphasis is placed on a target system (urine-based detection of analytes indicative of an infection with tuberculosis).

Team

Sören LehmkuhlKIT
Project leader

Prof. Dr. Sören Lehmkuhl
KIT - IMT

Simon FleischerKIT
Doctoral researcher

Simon Fleischer
KIT - IMT